June 19th 2024
A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.
May 2nd 2024
A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.
A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.
April 30th 2024
The role of health care specialty pharmacies has expanded.
December 8th 2023
The analysis revealed deeper issues created by payer and manufacturer lockouts placed on Integrated Health System Specialty Pharmacies.
Wilate Approved for Hemophilia A Treatment
Also indciated to control bleeding and perioperative management.
How to Prevent Pharmacist Burnout
Why is pharmacy work so stressful, and how can pharmacists take care of that stress?
Brolucizumab-dbll Approved by FDA for Wet AMD
Injection for leading cause of severe vision loss and legal blindness.
FDA Approves Trifarotene Cream for Acne Treatment
First new treatment of its kind in over 20 years.
Enteric Zoster: Hidden Shingles Threat
Characterized by severe abdominal pain.
Flu Shot May Be a COPD Lifesaver
Only 50% of COPD patients are estimated to be vaccinated.
Opinion: The Truth About ARCOS and the Opioid Epidemic
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
Biosimilars: Some Call for ‘Cautious Optimism’
Biosimilars may need more time to devleop in the market.
Rituximab Gains First Pediatric Approval
For granulomatosis with microscopic polyangiitis in children.
FDA Approves Canagliflozin Indication Expansion
Now approved for risk reductions in patients with type 2 diabetes mellitus.
Generics of Older Drugs Could Have Saved Medicare Billions, Study Says
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
Biosimilars Need Access and Cost Examinations
Biologic medicines could lower spending by $153 billion by 2023.
FDA Approves Jynneos for Smallpox and Monkeypox in Adults
Will be part of the U.S.’s public health emergency medical supplies and pharmaceuticals.
FDA Urged to Expedite Ranitidine Recalls
Online pharmacy that discovered the impurity discontinues sales.
Investigational Guillain-Barré Syndrome Treatment Granted FDA Fast Track Designation
Monoclonal antibody for autoimmune and neurodegenerative disorders.
What is a Pharmacy Desert?
Caused by lower income, insurance status, higher prices, poor transportation, long distances.
Patient Services are Crucial to the Economics of Pharmacy
Layoffs highlight increasing jobs problem.
At a Glance: Asthma Biologics
Obinutuzumab Receives Breakthrough Therapy Designation from FDA
Monoclonal antibody shows potential for lupus nephritis treatment.
Antimicrobial Stewardship: Protecting Global Health
Programs shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.
Vaccinations Are Increasingly Important as Hepatitis A Epidemic Grows
23,600 cases across 29 states since 2016.
Fear Motivates Vaccinations, New Study Finds
Fear, one's faith in the government, and likelihood of exposure are leading factors.
Optimism for AI in Cancer Care
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.
New Drug Review: Pretomanid for Highly Drug Resistant Tuberculosis
Indicated as part of a three-drug oral combination.
Oncology Market Remains Robust, Says Report
The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.
Tenapanor Approved for Adults with IBS-C
NHE3 inhibitor administered as 50 mg oral tablets.
Asthma Care Complications
New medications and treatment guidelines
FDA Warns of NDMA Traces in Ranitidine Products
Patients are still allowed to take medicines as prescribed.
DEA to Slash Opioid Production
Fentanyl, oxymorphone, and hydrocodone face greatest cuts.
Senate Finance Committee Wants Trump Action on DIR Fees
Eight pharmacy groups lauded a letter urging the Trump administration to reform direct and indirect remuneration (DIR) fees.